Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.31 USD
Change Today 0.00 / 0.00%
Volume 818.3K
VVUS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John L. Slebir Esq.

Senior Vice President of Business Development, General Counsel and Secretary, VIVUS Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

50$1,196,690
As of Fiscal Year 2014

Background*

Mr. John L. Slebir, Esq. has been Senior Vice President of Business Development and General Counsel of VIVUS Inc. since January 2014 and as its Secretary since June 2012. Mr. Slebir has been a General Counsel of Cardiva Medical, Inc. since July 2006. He was an Attorney of Wilson, Sonsini, Goodrich & Rosati and He practices corporate and securities law and his practice areas include corporate finance, corporate law and governance, mergers and acquisitions, and venture ...

Read Full Background

Corporate Headquarters*

351 East Evelyn Avenue
Mountain View, California 94041

United States

Phone: 650-934-5200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

JD 1991
Santa Clara University
BA 1987
San Diego State University

Other Affiliations*

Annual Compensation*

Salary$425,000
Total Annual Compensation$425,000

Stock Options*

Restricted Stock Awards$336,350
All Other Compensation$10,400
Exercisable Options290,000
Unexercisable Options51,000
Total Number of Options341,000

Total Compensation*

Total Annual Cash Compensation$605,400
Total Short Term Compensation$425,000
Other Long Term Compensation$346,750
Total Calculated Compensation$1,196,690
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VVUS:US $2.31 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jack Lief Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Arena Pharmaceuticals, Inc.
$746.8K
Lars Rebien Sørensen Chief Executive Officer and Member of Executive Management
Novo Nordisk A/S
kr15.2M
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
¥230.0M
Manoj Kumar Managing Director and Director
GlaxoSmithKline Consumer Healthcare Limited
--
Michael A. Narachi M.S., M.B.A.Chief Executive Officer, President and Director
Orexigen Therapeutics, Inc.
$640.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIVUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.